Franklin Biotechnology Discovery Fund

Average Annual Total Returns [further-information] As of 11/30/2019

Month EndAs of 11/30/2019 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) 13.82 7.27 2.25 15.01 10.19
Fund with Sales Charge (%) (POP) 12.82 7.27 2.25 15.01 10.19
NASDAQ Biotechnology Index (%) 9.50 9.45 3.38 16.74 11.70
S&P 500 Index (%) 16.11 14.89 10.98 13.44 7.70
Quarter EndAs of 09/30/2019 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) -18.11 -0.73 -0.05 12.17 9.25
Fund with Sales Charge (%) (POP) -18.90 -0.73 -0.05 12.17 9.25
NASDAQ Biotechnology Index (%) -18.45 1.10 1.81 14.19 10.87
S&P 500 Index (%) 4.25 13.40 10.84 13.24 7.48

After-Tax Average Annual Total Returns [further-information] As of 11/30/2019

Month EndAs of 11/30/2019 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold 12.51 6.23 0.89 13.79
Fund without Sales Charge (%) (NAV) After Shares Sold 8.30 5.31 1.36 12.31
Fund with Sales Charge (%) (POP) Before Shares Sold 11.51 6.23 0.89 13.79
Fund with Sales Charge (%) (POP) After Shares Sold 7.71 5.31 1.36 12.31
Quarter EndAs of 09/30/2019 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold -19.05 -1.69 -1.38 10.98
Fund without Sales Charge (%) (NAV) After Shares Sold -10.48 -0.71 -0.26 9.92
Fund with Sales Charge (%) (POP) Before Shares Sold -19.84 -1.69 -1.38 10.98
Fund with Sales Charge (%) (POP) After Shares Sold -10.95 -0.71 -0.26 9.92

Calendar Year Returns

2018 2017 2016 2015 2014 2013
Fund without Sales Charge (%) (NAV) -16.34 17.91 -17.75 4.71 32.95 67.44
Fund with Sales Charge (%) (POP) -17.15 16.91 -18.54 3.75 31.95 66.44
NASDAQ Biotechnology Index (%) -9.32 21.06 -21.68 11.42 34.32 65.97
S&P 500 Index (%) -4.38 21.83 11.96 1.38 13.69 32.39

Cumulative Total Returns [further-information] As of 11/30/2019

Month EndAs of 11/30/2019 3 Month YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) 15.65 29.55 13.82 23.44 11.77 304.87 762.81
Fund with Sales Charge (%) (POP) 14.65 28.55 12.82 23.44 11.77 304.87 762.81
NASDAQ Biotechnology Index (%) 16.09 23.37 9.50 31.09 18.10 370.05 1,067.34
S&P 500 Index (%) 7.86 27.63 16.11 51.62 68.34 252.89 419.20
Quarter EndAs of 09/30/2019 3 Month YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) -14.44 5.61 -18.11 -2.17 -0.25 215.35 603.37
Fund with Sales Charge (%) (POP) -15.29 4.61 -18.90 -2.17 -0.25 215.35 603.37
NASDAQ Biotechnology Index (%) -8.76 2.76 -18.45 3.32 9.39 276.85 872.33
S&P 500 Index (%) 1.70 20.55 4.25 45.80 67.27 246.74 390.39

MODERN PORTFOLIO THEORY (MPT) STATISTICSAs of 11/30/2019 (updated monthly)

3 YR 5 YR 10 YR
Standard Deviation (Fund) 22.56 24.81
Standard Deviation (NASDAQ Biotechnology Index) 20.74 23.21 21.08
Beta 1.05 1.04
Sharpe Ratio 0.25 0.05
Information Ratio -0.37 -0.20
Tracking Error 5.89 5.71

ADDITIONAL RISK STATISTICSAs of 11/30/2019 (updated monthly)

3 YR 5 YR 10 YR
Beta Bull 1.04 0.97
Beta Bear 0.93 1.01
Bull Bear Capture Ratio 0.96 1.01
% of Positive Months 52.78 56.67
Gains/Losses 1.35 1.17
Maximum Drawdown
23.74 37.91

SALES CHARGE, EXPENSES & FEES As of 09/01/2019 (updated annually)

Gross Expense Ratio 1.79%
Net Expense Ratio [further-information] 1.77%
Max Initial Sales Charge 0.00%
CDSC 1.00%

Volatility Measures [further-information] As of 11/30/2019 Updated Monthly, based on a 3-year period

Beta 1.05
Sharpe Ratio 0.25
Standard Deviation 22.56

Benchmarks

A benchmark is a comparable broad-based index that can be used to evaluate a fund's performance.

  • NASDAQ Biotechnology Index
  • S&P 500 Index